Boothbay Fund Management’s Lexaria Bioscience Corp. Warrant LEXXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-78,950
| Closed | -$98.7K | – | 1583 |
|
|
2023
Q4 | $98.7K | Hold |
78,950
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q3 | $78.9K | Hold |
78,950
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q2 | $57.7K | Hold |
78,950
| – | – | ﹤0.01% | 1443 |
|
|
2023
Q1 | $215K | Hold |
78,950
| – | – | ﹤0.01% | 1466 |
|
|
2022
Q4 | $194K | Hold |
78,950
| – | – | ﹤0.01% | 1388 |
|
|
2022
Q3 | $193K | Hold |
78,950
| – | – | ﹤0.01% | 1581 |
|
|
2022
Q2 | $235K | Hold |
78,950
| – | – | 0.01% | 1395 |
|
|
2022
Q1 | $261K | Hold |
78,950
| – | – | 0.01% | 1343 |
|
|
2021
Q4 | $318K | Hold |
78,950
| – | – | 0.01% | 1076 |
|
|
2021
Q3 | $494K | Hold |
78,950
| – | – | 0.01% | 898 |
|
|
2021
Q2 | $553K | Hold |
78,950
| – | – | 0.02% | 826 |
|
|
2021
Q1 | $443K | Buy |
+78,950
| New | +$443K | 0.02% | 815 |
|